Cost Implication of Inappropriate Empiric Antibiotics in Gram-Negative Infections.
作者信息
Juang Paul, Lindsey Parker, Micek Scott T, Kollef Marin H
机构信息
Department of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, MO, USA.
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
出版信息
Hosp Pharm. 2024 Dec 12:00185787241303035. doi: 10.1177/00185787241303035.
Abstract
摘要
相似文献
1
Cost Implication of Inappropriate Empiric Antibiotics in Gram-Negative Infections.革兰氏阴性菌感染中不恰当经验性使用抗生素的成本影响
Hosp Pharm. 2024 Dec 12:00185787241303035. doi: 10.1177/00185787241303035.
2
Using Culture Sensitivity Reports to Optimize Antimicrobial Therapy: Findings and Implications of Antimicrobial Stewardship Activity in a Hospital in Pakistan.利用文化敏感性报告优化抗菌治疗：巴基斯坦一家医院抗菌药物管理活动的发现和意义。
Medicina (Kaunas). 2023 Jul 2;59(7):1237. doi: 10.3390/medicina59071237.
3
Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.革兰氏阴性菌菌血症；英国急性医院经验性抗生素治疗和结局的多中心前瞻性评估。
Clin Microbiol Infect. 2016 Mar;22(3):244-51. doi: 10.1016/j.cmi.2015.10.034. Epub 2015 Nov 11.
4
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.在没有肺炎的患者中，经验性抗生素等待支气管肺泡灌洗数据会显著改变菌群，但如果随后发生肺炎，则不会改变耐药谱。
J Surg Res. 2013 May;181(2):323-8. doi: 10.1016/j.jss.2012.07.021. Epub 2012 Jul 26.
5
Impact of inappropriate empiric antimicrobial therapy on mortality in pediatric patients with bloodstream infection: a retrospective observational study.不恰当的经验性抗菌治疗对儿童血流感染患者死亡率的影响：一项回顾性观察研究。
J Chemother. 2019 Nov-Dec;31(7-8):388-393. doi: 10.1080/1120009X.2019.1623362. Epub 2019 May 30.
6
Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward.在耐药挑战的情况下保留日渐减少的基于β-内酰胺类的经验性治疗革兰氏阴性感染的治疗方案：经验教训和未来方向。
Microb Drug Resist. 2020 Jun;26(6):637-651. doi: 10.1089/mdr.2019.0195. Epub 2019 Dec 17.
7
Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatients.美国住院患者中与经验性革兰氏阴性菌抗生素升级和降级相关的临床、背景及医院层面因素。
JAC Antimicrob Resist. 2023 May 13;5(3):dlad054. doi: 10.1093/jacamr/dlad054. eCollection 2023 Jun.
8
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.基于英国细菌分离株的体外监测，比较头孢洛扎/他唑巴坦联合甲硝唑与哌拉西林/他唑巴坦作为经验性治疗复杂腹腔内感染的成本效益。
J Med Econ. 2017 Aug;20(8):840-849. doi: 10.1080/13696998.2017.1333960. Epub 2017 Jun 8.
9
Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.严重医院获得性感染的抗菌治疗模式：经验性选择、适当治疗的比例和适应率——一项多中心、观察性研究，纳入重症患者。
Int J Antimicrob Agents. 2010 Apr;35(4):375-81. doi: 10.1016/j.ijantimicag.2009.11.015. Epub 2010 Feb 1.
10
Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.928 家美国医院中经验性革兰氏阴性抗生素使用的模式、预测因素和中心间变异性。
Clin Infect Dis. 2023 Feb 8;76(3):e1224-e1235. doi: 10.1093/cid/ciac504.
本文引用的文献
1
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.肠杆菌科细菌引起的尿路感染、肺炎和败血症住院患者的碳青霉烯类耐药性、不适当的经验性治疗及预后
BMC Infect Dis. 2017 Apr 17;17(1):279. doi: 10.1186/s12879-017-2383-z.
2
The true cost of antimicrobial resistance.抗菌药物耐药性的真实代价。
BMJ. 2013 Mar 11;346:f1493. doi: 10.1136/bmj.f1493.
3
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.与医疗保健相关感染相关的抗微生物药物耐药病原体：2009-2010 年向疾病预防控制中心国家医疗保健安全网络报告的数据摘要。
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14. doi: 10.1086/668770. Epub 2012 Nov 27.
4
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.关于革兰氏阴性菌耐药性对重症监护病房治疗结果影响的研究综述。
Crit Care Med. 2009 Apr;37(4):1463-9. doi: 10.1097/CCM.0b013e31819ced02.
5
The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.抗菌药物耐药性与患者预后之间的关系：死亡率、住院时间和医疗费用。
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9. doi: 10.1086/499406.
6
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.初始抗菌治疗不充分对产超广谱β-内酰胺酶肠杆菌科细菌所致感染死亡率的影响：因感染部位而异
Arch Intern Med. 2005 Jun 27;165(12):1375-80. doi: 10.1001/archinte.165.12.1375.
7
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.充分的经验性抗生素治疗对脓毒症入住重症监护病房患者预后的影响。
Crit Care Med. 2003 Dec;31(12):2742-51. doi: 10.1097/01.CCM.0000098031.24329.10.
8
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.感染的抗菌治疗不充分：危重症患者医院死亡的一个危险因素。
Chest. 1999 Feb;115(2):462-74. doi: 10.1378/chest.115.2.462.
Zotero 插件